Nuchev Limited Reports 4.6% FY26 Revenue Growth Driven by Oli6 Retail Expansion and New Product Launches

FY26 Revenue Growth Accelerates in Final Quarter

Nuchev’s FY26 group sales revenue totaled $24.1 million, up 4.6% from the previous financial year. Revenue growth accelerated notably in the final quarter, with June 2026 quarterly sales reaching $2.9 million, a 26.7% increase compared to June 2025. This upward trend indicates strong underlying momentum in core business channels, positioning Nuchev for potential enhanced performance in FY27. Despite challenges in international markets, particularly Vietnam, domestic strength primarily drove this growth.

The June 2026 quarter generated $7.4 million in group revenue, up 57% quarter-on-quarter and 17% year-on-year. Oli6 Nutritionals and Brauer combined revenue was $6.0 million, reflecting 88% growth quarter-on-quarter and 30% year-on-year. Practitioner channel revenue declined slightly to $1.5 million, down 5% quarter-on-quarter due to softer year-end trading conditions. These unaudited figures remain subject to FY26 year-end audit confirmation.

Oli6 Expands Domestic Retail Footprint with New Children’s Snacking and Goat Nutrition Products

Oli6, Nuchev’s flagship infant nutrition brand, continued strong domestic retail performance in June 2026 across key grocery and pharmacy customers such as Chemist Warehouse, Coles, and Woolworths. Positive retail scan data confirmed sustained consumer demand and shelf presence. This core infant formula strength forms a solid base for the company’s growth strategy.

During the quarter, Oli6 broadened its product range by launching six children’s snacking SKUs, two Nighty Night Goat functional food SKUs, and reintroducing Full Cream Goat Milk Powder in 1kg and new 400g sizes. This strategic diversification positions Oli6 as a comprehensive goat nutrition brand beyond infant formula. The launch of the dedicated Oli6Goat.com website in June 2026 enhances direct-to-consumer engagement for non-infant formula products, supporting revenue diversification and leveraging existing brand equity and distribution channels.

Vietnam Regulatory Delays Impact International Revenue Growth

International revenue remained subdued in June 2026, primarily due to product registration delays in Vietnam. Changes to local regulatory requirements have created uncertainty around product registration timelines and import documentation, delaying new product launches in this market. These challenges reflect short-term administrative hurdles rather than diminished international expansion interest.

Management is collaborating with local partners to clarify regulatory pathways and facilitate product launches. The company views these delays as temporary and expects resolution to unlock additional international revenue growth. Investors should watch for updates on Vietnam regulatory progress and order conversions, which will be key indicators of management’s effectiveness in navigating these challenges.

BioPractica Practitioner Channel Shows Promise with New Ecommerce Platform

The practitioner channel experienced softness in June 2026, with revenue of $1.5 million down 5% quarter-on-quarter due to weaker trading conditions and reduced distributor purchasing. However, BioPractica showed positive signs, supported by strong New Zealand market performance and the launch of a new practitioner ecommerce website consolidating multiple brands including BioPractica, Magnesium Diasporal, Basica, and Heel.

This new B2B ecommerce platform aims to enhance direct sales to clinicians, pharmacies, and health food retailers. Nuchev plans to improve distributor execution, expand product offerings, increase active practitioner accounts, and stabilize sales rhythms to drive recovery and growth in this channel.

Brauer Brand Strengthens Contribution with Supply Improvements

Brauer, Nuchev’s complementary medicines brand, gained momentum in June 2026, benefiting from improved supply and recovery from prior stock shortages. Combined Oli6 Nutritionals and Brauer revenue of $6.0 million in the quarter highlights Brauer’s growing impact on group performance. The "Strength in Every Drop" campaign launched during the quarter aims to boost brand visibility and customer engagement.

Both Oli6 Goat and Oat Bites and Brauer Baby Sleep were finalists in the Clean + Conscious Awards, underscoring product quality and market positioning. The resolution of supply constraints and positive momentum suggest Brauer has significant potential to contribute further to revenue growth.

$4.0 Million Working Capital Facility Supports Growth Strategy

Nuchev secured a $4.0 million unsecured working capital facility from H&S during the June 2026 quarter, enhancing financial flexibility to fund growth initiatives. The company drew $1.5 million under this facility to support product development, inventory build, and distribution expansion, with $2.5 million remaining available for future needs.

This facility demonstrates confidence from the funding provider and reduces reliance on internal cash flow for growth investments. The company’s cash position stood at $2.1 million at 30 June 2026, balancing operational cash burn and facility utilization.

Focused Working Capital Management and Cash Flow Discipline

Active management of cash and working capital continued through June 2026, focusing on inventory, receivables, and supplier payments. Combined with the undrawn facility, Nuchev has approximately $4.6 million in liquidity to support operations and growth. The company prioritizes sustainable growth by balancing expansion with financial discipline.

Inventory management remains critical, especially given Brauer’s recent recovery from stock shortages. Working capital discipline will be a key indicator of management’s execution capability and influence the pace of growth initiatives. Investors should monitor quarterly working capital and cash flow metrics for signs of improved operational cash generation.

New Product Development and Portfolio Diversification Drive Category Expansion

Product innovation increased significantly during the June 2026 quarter across retail and practitioner channels. Oli6 launched children’s snacking products, Nighty Night Goat functional foods, and new Full Cream Goat Milk Powder formats, extending the brand beyond infant formula and opening new revenue streams.

Brand messaging updates for Skin Physics and Brauer, including Brauer’s "Strength in Every Drop" campaign, enhanced market positioning. Digital efforts supported direct-to-consumer sales for Skin Physics and Rapid Loss brands. BioPractica’s ecommerce relaunch consolidated practitioner brands into a unified digital marketplace. External recognition via Clean + Conscious Awards finalists further validates product quality and differentiation.

Market Position and Competitive Landscape in Nutritional and Complementary Medicine Sectors

Nuchev operates in Australia’s growing nutritional supplements and complementary medicines markets, driven by rising consumer health awareness. Oli6 holds a premium position in the goat-based infant formula category, with strong distribution through Chemist Warehouse, Coles, and Woolworths. Positive retail scan data indicates Oli6 is maintaining or growing market share, while diversification into children’s snacking and goat nutrition expands its addressable market.

The practitioner channel serves naturopaths, nutritionists, and health food retailers, with BioPractica’s new ecommerce platform enhancing direct engagement. Brauer’s complementary medicines focus on sleep and wellness taps into established natural health demand. Despite practitioner channel softness and international regulatory delays, Nuchev’s multi-channel presence, new product launches, and digital initiatives position it well within the wellness sector. Execution challenges remain, particularly in establishing consistent sales and navigating international regulations.